The FDA has approved Moderna’s mRNA seasonal influenza vaccine mFLUSIVA [...]
Nanexa has entered into a licence and option agreement with [...]
BridgeBio Pharma reported $36.7 million in US net revenue for [...]
The FDA has approved Moderna’s mRNA seasonal influenza vaccine mFLUSIVA [...]
Nanexa has entered into a licence and option agreement with [...]
BridgeBio Pharma reported $36.7 million in US net revenue for [...]